Lecithin does not affect EEG spectral analysis or P 300 in Alzheimer disease
- 1 November 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 32 (11) , 1260
- https://doi.org/10.1212/wnl.32.11.1260
Abstract
We studied 10 patients with Alzheimer disease by measuring EEG compressed spectral analysis and the P300 latency and topography before and after 2 weeks of lecithin therapy. There was a significant positive correlation between the degree of dementia measured by the Blessed Dementia Scale and the amount of EEG delta activity. The P300 latency was related to the ability to detect the rare tones in the P300 paradigm. Lecithin therapy increased mean plasma choline levels but did not affect EEG power or the P300 latency or topography.This publication has 12 references indexed in Scilit:
- EEG and cognitive impairment in presenile dementiaActa Neurologica Scandinavica, 1979
- Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indicesMetabolism, 1978
- Physostigmine: Improvement of Long-Term Memory Processes in Normal HumansScience, 1978
- Human Serial Learning: Enhancement with Arecholine and Choline Impairment with ScopolamineScience, 1978
- Choline: Selective enhancement of serial learning and encoding of low imagery words in manLife Sciences, 1978
- Memory and cognitive function in manNeurology, 1977
- Trans-synaptic induction of adrenomedullary tyrosine hydroxylase activity by choline: evidence that choline administration can increase cholinergic transmission.Proceedings of the National Academy of Sciences, 1977
- Effects of oral choline administration on serum and CSF choline levels in patients with Huntington's Disease1Journal of Neurochemistry, 1977
- The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly SubjectsThe British Journal of Psychiatry, 1968
- Familial Alzheimer's diseaseNeurology, 1963